| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/26/2006 | US20060018951 pH-responsive film for intravaginal delivery of a beneficial agent |
| 01/26/2006 | US20060018950 Body ornamentation |
| 01/26/2006 | US20060018949 Injectable biodegradable drug delivery system |
| 01/26/2006 | US20060018942 Polymeric microbeads having characteristics favorable for bone growth, and process including three dimensional printing upon such microbeads |
| 01/26/2006 | US20060018938 Foam skin cream, use of the foam skin protection cream and a process of its preparation |
| 01/26/2006 | US20060018934 Novel drug delivery system |
| 01/26/2006 | US20060018933 Novel drug delivery system |
| 01/26/2006 | US20060018891 Soft gel capsule, beta-carotene; vitamin E; yellow beeswax;a mixture of mono-, di, tri-glycerides of 16 to 18 carbon chain length and polyglycerol oleate; rice bran oil |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018867 Cosmetic composition and production thereof |
| 01/26/2006 | US20060018852 cosmetic and dermatological compositions containing hydrocortisone, a glycol and a thickening or gelling agent; chemical stability |
| 01/26/2006 | US20060018849 Cosmetic or dermatological preparations of the oil-in-water type |
| 01/26/2006 | US20060018847 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations |
| 01/26/2006 | US20060018842 Composition and method for delivery of phytochemicals |
| 01/26/2006 | US20060018839 Synergistic atorvastatin or atorvastsin calcium and donepezil or donepezil hydrochloride administered seperately or concurrently; nasal dosage forms; Alzheimer's Disease |
| 01/26/2006 | US20060018835 Nanoparticles with inorganic core and methods of using them |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | US20060018233 Read write device for optical memory and method therefore |
| 01/26/2006 | US20060016451 Delivery sysem and a manufacturing process of a delivery system |
| 01/26/2006 | DE19938668B4 Tränenersatzmittel Artificial tears |
| 01/26/2006 | DE102004032375A1 Faser, insbesondere Hohlfaser und deren Verwendung Fiber, in particular hollow fiber and the use thereof |
| 01/26/2006 | CA2574682A1 Device for transdermal delivery of active principles |
| 01/26/2006 | CA2574623A1 Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva |
| 01/26/2006 | CA2574614A1 Sterile freezing, drying, storing, assaying and filling process (sfd-saf process) (pellet freeze-drying process for parenteral biopharmaceuticals) |
| 01/26/2006 | CA2574302A1 Stable compositions containing outer membrane vesicles, methods of manufacturing |
| 01/26/2006 | CA2574188A1 Anti-histaminic composition |
| 01/26/2006 | CA2574085A1 Gonadotropin releasing hormone antagonists |
| 01/26/2006 | CA2573985A1 A pharmaceutical composition comprising gabapentin |
| 01/26/2006 | CA2572928A1 Sustained-release preparations containing topiramate and the producing method thereof |
| 01/26/2006 | CA2571327A1 Oral care compositions |
| 01/26/2006 | CA2571107A1 Oral care film |
| 01/26/2006 | CA2570960A1 Compositions and methods for treating central precocious puberty |
| 01/26/2006 | CA2569015A1 Modified release formulation of memantine |
| 01/26/2006 | CA2553065A1 New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 01/25/2006 | EP1619254A1 Transfer of mRNA using polycationic compounds |
| 01/25/2006 | EP1618897A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 01/25/2006 | EP1618896A2 Dissolvable oxides for biological applications |
| 01/25/2006 | EP1618895A1 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |
| 01/25/2006 | EP1618894A1 Composition for injection |
| 01/25/2006 | EP1618889A2 Influenza Vaccine |
| 01/25/2006 | EP1618883A1 Agent for preventing and ameliorating constipation |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618873A1 Granule for the control release of tamsulosin, containing alginate |
| 01/25/2006 | EP1618864A1 High oil content oil-in-water emulsion and its use in cosmetics |
| 01/25/2006 | EP1618803A1 A flameless electronic atomizing cigarette |
| 01/25/2006 | EP1618797A1 Method of producing edible films including aspartame |
| 01/25/2006 | EP1617895A2 Rf medical device |
| 01/25/2006 | EP1617873A2 Mitomycin conjugates cleavable by thiols |
| 01/25/2006 | EP1617871A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 01/25/2006 | EP1617859A1 Methods and compositions using gonadotropin hormone releasing hormone |
| 01/25/2006 | EP1617850A2 Delivery vehicle for silver ions |
| 01/25/2006 | EP1617847A2 Methods for the controlled delivery of pharmacologically active compounds |
| 01/25/2006 | EP1617846A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| 01/25/2006 | EP1617842A1 Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these |
| 01/25/2006 | EP1617838A1 Composition for oral administration containing alkylene dioxybenzene derivative |
| 01/25/2006 | EP1617828A2 Nano-sized vehicles transporting a therapeutic agent and at least one drug resistance modulator for the treatment of multi drug resistance |
| 01/25/2006 | EP1617826A2 The dispersible alendronate microparticle formulation |
| 01/25/2006 | EP1617825A2 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 01/25/2006 | EP1617824A1 Pharmaceutical composition containing ribavirin as active substance and method of manufacturing thereof |
| 01/25/2006 | EP1617823A1 A composition material for transmucosal delivery |
| 01/25/2006 | EP1617822A2 Tablets and methods for modified release of hydrophilic and other active agents |
| 01/25/2006 | EP1617821A1 Chrono delivery formulations and method of treating atrial fibrillation |
| 01/25/2006 | EP1617820A2 Dry power inhaler devices and dry power formulations for enhancing dosing efficiency |
| 01/25/2006 | EP1617819A1 Radioactively marked microparticles, method for the production thereof and use of the same |
| 01/25/2006 | EP1617818A1 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| 01/25/2006 | EP1617817A2 Oral spray to reduce cold symptoms and duration of same |
| 01/25/2006 | EP1617816A2 Nanoparticulate meloxican formulations |
| 01/25/2006 | EP1617815A2 Process for making gel films |
| 01/25/2006 | EP1617814A2 Method for the dispersion of water-soluble or hydrophilic substances in a supercritically pressurized fluid |
| 01/25/2006 | EP1617808A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 01/25/2006 | EP1617799A2 Hemophilia treatment by inhalation of coagulation factors |
| 01/25/2006 | EP1617785A2 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem |
| 01/25/2006 | EP1617754A2 User interface for infusion pump remote controller and method of using the same |
| 01/25/2006 | EP1465620A4 Novel composition of carvedilol |
| 01/25/2006 | EP1392241A4 System for osmotic delivery of pharmaceutically active agents |
| 01/25/2006 | EP1245232B1 Oral solid preparation |
| 01/25/2006 | EP1135127B1 New pharmaceutical composition and the process for its preparation |
| 01/25/2006 | EP1064087B1 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| 01/25/2006 | EP1001757B1 Fast-acting analgesic |
| 01/25/2006 | EP0813403B1 Stable water-in-oil emulsion system |
| 01/25/2006 | EP0759694B1 Method for in vivo delivery of therapeutic agents via liposomes |
| 01/25/2006 | CN1726076A Methods and apparatus for making particles using spray dryer and in-line jet mill |
| 01/25/2006 | CN1726049A Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 01/25/2006 | CN1726048A Gastric acid secretion inhibiting composition |
| 01/25/2006 | CN1726045A Freeze-dried interferon-gamma composition for transpulmonary administration and inhalation system therefor |
| 01/25/2006 | CN1726044A Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| 01/25/2006 | CN1726043A Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 01/25/2006 | CN1726038A Tiotropium containing HFC solution formulations |
| 01/25/2006 | CN1726037A Treatment of headache with antipsychotics delivered by inhalation |
| 01/25/2006 | CN1726035A Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 01/25/2006 | CN1726032A Pharmaceutical compositions of sertaconazole for vaginal use |
| 01/25/2006 | CN1726028A Solid drug for oral use |
| 01/25/2006 | CN1726027A Controlled release preparations comprising tramadol and topiramate |
| 01/25/2006 | CN1726024A Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 01/25/2006 | CN1726017A Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 01/25/2006 | CN1726014A Novel dry powder inhalation system for transpulmonary administration |
| 01/25/2006 | CN1726013A Non gelatin films with improved barrier properties |
| 01/25/2006 | CN1726012A Controlled-release of an active substance into a high fat environment |
| 01/25/2006 | CN1726011A Stable topiramate formulations |
| 01/25/2006 | CN1726010A Process for preparing combination pharmaceutical formulations using supercritical fluids |